Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Delcath Systems, Inc.    

DELCATH SYSTEMS, INC.
Mes dernières consult.
Most popular
Report
 SummaryChartsNewsCalendarCompanyFinancials 
Company
Delcath Systems, Inc. is a pharmaceutical and medical device company which focuses on oncology and liver cancer therapy.It develops and commercializes Melphalan Hydrochloride for Injection which is a proprietary product for use with the Delcath Hepatic Delivery System.The company was founded in... 
More about the company
Latest news on DELCATH SYSTEMS, INC.
11/20 DELCATH SYSTEMS, INC. : Change in Directors or Principal Officers, Financial Sta..
11/20 DELCATH : Enhances Board of Directors With Appointment of Industry Veteran, Dr. ..
11/16 DELCATH SYSTEMS, INC. (NASDAQ : DCTH) Files An 8-K Entry into a Material Definit..
11/15 DELCATH : Announces Third Quarter 2017 Financial Results
11/14 DELCATH : Management's Discussion and Analysis of Financial Condition and Result..
11/06 DELCATH SYSTEMS, INC. : REVERSE SPLIT: 1 for 350
11/03 DELCATH SYSTEMS, INC. (NASDAQ : DCTH) Files An 8-K Amendments to Articles of Inc..
11/03 DELCATH SYSTEMS, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fisc..
10/12 DELCATH SYSTEMS, INC. (NASDAQ : DCTH) Files An 8-K Entry into a Material Definit..
10/11 DELCATH SYSTEMS, INC. : Entry into a Material Definitive Agreement, Financial St..
More news
Sector news : Medical Prosthetics
11/13 Poor earnings updates keep European shares at seven-week low
11/13 SONOVA : misses sales, profit forecasts as U.S. overhaul bites
11/03 ESSILOR INTERNATIONAL : EU regulators suspend Luxottica, Essilor probe, await da..
11/03DJESSILOR INTERNATIONAL : EU Regulator Has Suspended Essilor, Luxottica Probe -Reu..
11/03 SMITH & NEPHEW : Under pressure Smith & Nephew to focus on efficiency
More sector news : Medical Prosthetics
News from SeekingAlpha
11/15 YOUR DAILY PHARMA SCOOP : Portola Ahead Of Catalysts, AstraZeneca Gets Two FDA A..
11/15 DELCATH SYSTEMS INC NEW reports Q3 results
11/14 Delcath Systems reports Q3 results
10/11 Delcath files S-1 for equity offering; shares down 5%
09/22 Delcath inks deal with convertible debt holders for short-term operating capi..
Chart DELCATH SYSTEMS, INC.
Duration : Period :
Delcath Systems, Inc. Technical Analysis Chart | US24661P5008 | 4-Traders
Technical analysis trends DELCATH SYSTEMS, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Managers
NameTitle
Jennifer K. Simpson President, Chief Executive Officer & Director
Roger G. Stoll Non-Executive Chairman
John Purpura Executive Vice President-Global Operations
Barbra C. Keck Secretary, Chief Financial & Accounting Officer
William Dodge Rueckert Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
DELCATH SYSTEMS, INC.-91.09%169
MEDTRONIC PLC15.60%111 971
STRYKER CORPORATION29.98%58 280
BECTON DICKINSON AND CO37.02%51 619
BAXTER INTERNATIONAL44.43%35 005
ESSILOR INTERNATIONAL-0.89%27 405